Saudi Chemical Holding Company (2230.SR)
- Previous Close
7.95 - Open
7.99 - Bid 7.73 x --
- Ask 7.72 x --
- Day's Range
7.70 - 8.00 - 52 Week Range
2.98 - 8.37 - Volume
5,623,456 - Avg. Volume
10,155,683 - Market Cap (intraday)
6.526B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
35.18 - EPS (TTM)
0.22 - Earnings Date --
- Forward Dividend & Yield 0.05 (0.65%)
- Ex-Dividend Date Jan 28, 2024
- 1y Target Est
--
Saudi Chemical Holding Company manufacture, wholesale, and retail trade of medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools and equipment in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Explosive; Medicine and Medical Supplies; and Production of Ammonium Nitrate. It also manufactures and sells explosives and related products for civil and military uses, as well as hospitals and medical centers supplies and related spare parts, and food items; and manufacture of ammonium nitrate, as well as provides technical support services in explosions. In addition, the company engages in the wholesale and retail trade of cosmetics, perfumes, beauty soups, and other supplies; and packaging and storing of medicines and other medical products. The company was founded in 1972 and is based in Riyadh, the Kingdom of Saudi Arabia.
www.saudichemical.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 2230.SR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2230.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2230.SR
Valuation Measures
Market Cap
6.53B
Enterprise Value
7.62B
Trailing P/E
35.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.34
Price/Book (mrq)
3.63
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
21.24
Financial Highlights
Profitability and Income Statement
Profit Margin
3.77%
Return on Assets (ttm)
4.13%
Return on Equity (ttm)
10.59%
Revenue (ttm)
4.85B
Net Income Avi to Common (ttm)
182.89M
Diluted EPS (ttm)
0.22
Balance Sheet and Cash Flow
Total Cash (mrq)
134.11M
Total Debt/Equity (mrq)
67.79%
Levered Free Cash Flow (ttm)
310.15M
Company Insights: 2230.SR
2230.SR does not have Company Insights